Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Althaus, Alison L., Ackley, Michael A., Belfort, Gabriel M., Gee, Steven M., Dai, Jing, Nguyen, David P., Kazdoba, Tatiana M., Modgil, Amit, Davies, Paul A., Moss, Stephen J., Salituro, Francesco G.,Journal:
Neuropharmacology
DOI:
10.1016/j.neuropharm.2020.108333
Date:
September, 2020
Fichier:
PDF, 2.44 MB
2020
File converter
Plus de résultats de recherche
More benefits 
